ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일
Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1
Relapsed B Cell Acute Lymphoblastic Leukemia (ALL); Refractory B Cell Acute Lymphoblastic Leukemia (ALL) · CD19
Acute Lymphoblastic Leukemia in Remission · CD19
Acute Lymphoblastic Leukemia; CD19 Positive · CD19
Acute Lymphoid Leukemia; Acute Lymphoblastic Leukemia · CD19
Acute Lymphoblastic Leukemia · CD19
Acute Lymphoblastic Leukemia, in Relapse; Non-Hodgkin's Lymphoma, Relapsed · CD19
Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19
Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma · CD19
B-cell Acute Lymphoblastic Leukemia · CD19
B-Cell Acute Lymphoblastic Leukemia, Adult; B-cell Lymphoma Refractory · CD19
Relapse B Acute Lymphoblastic Leukemia; Refactory Childhood Acute Lymphoblastic Leukemia · CD19
Acute Lymphoblastic Leukemia (ALL); Non Hodgkin Lymphoma (NHL) · CD19
Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19
B-cell Acute Lymphoblastic Leukemia; B-cell Non Hodgkin Lymphoma · CD19
Leukemia, Lymphoblastic, Acute, Lymphoma · CD19
B-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · CD22
7 / 12 pages
구조모아 (StructureMoa)항암 chemical structure spider web
KRMediMoa한의학·한약재 임상·근거 데이터
다음 갱신 D-5 · 마지막 9월 2일 · 방문 1,126 / 70,960